Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Glucose monohydrate; Sodium chloride; Potassium chloride; Magnesium chloride hexahydrate; Sodium acetate trihydrate ; Sodium gluconate
Baxter Holding B.V.
B05BB; B05BB02
Glucose monohydrate; Sodium chloride; Potassium chloride; Magnesium chloride hexahydrate; Sodium acetate trihydrate ; Sodium gluconate
5 percent weight/volume
Solution for infusion
Solutions affecting the electrolyte balance; electrolytes with carbohydrates
Marketed
2007-06-01
1 PACKAGE LEAFLET: INFORMATION FOR THE USER PLASMA-LYTE 148 & GLUCOSE 5% W/V SOLUTION FOR INFUSION Active substances: glucose, sodium chloride, potassium chloride, magnesium chloride hexahydrate, sodium acetate trihydrate and sodium gluconate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. This medicine is called `Plasma-Lyte 148 & Glucose 5% w/v Solution for Infusion’, but will be referred to as `Plasma-Lyte & Glucose Infusion’ throughout the remainder of this leaflet. WHAT IS IN THIS LEAFLET: 1. What Plasma-Lyte & Glucose Infusion is and what it is used for 2. What you need to know before you are given Plasma-Lyte & Glucose Infusion 3. How you will be given Plasma-Lyte & Glucose Infusion 4. Possible side effects 5. How to store Plasma-Lyte & Glucose Infusion 6. Contents of the pack and other information 1. WHAT PLASMA-LYTE & GLUCOSE INFUSION IS AND WHAT IT IS USED FOR Pharmacotherapeutic group: “Electrolytes with Carbohydrates” - ATC code: “B05BB02” Plasma-Lyte & Glucose Infusion is a solution of the following substances in water: - sugar (glucose) - sodium chloride - potassium chloride - magnesium chloride hexahydrate - sodium acetate trihydrate - sodium gluconate Glucose is one of the body’s sources of energy. This solution for infusion provides 220 kilocalories per litre. Sodium, potassium, magnesium, chloride, acetate and gluconate are chemical substances found in the blood. Plasma-Lyte & Glucose infusion is used: - to provide a source of fluid and carbohydrate (sugar) for example, in cases of: - burns - head injury - fractures - infection - peritoneal irritation (inflammation within the abdomen) - as a source of fluids during a surgical operation - in metabolic acido Read the complete document
HealthProductsRegulatoryAuthority 22March2019 CRN008KF8 Page1of11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Plasma-Lyte148&Glucose5%w/vsolutionforinfusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Glucosemonohydrate 55.00g/l SodiumChloride: 5.26g/l PotassiumChloride: 0.37g/l MagnesiumChloridehexahydrate: 0.30g/l SodiumAcetatetrihydrate: 3.68g/l SodiumGluconate: 5.02g/l Na + K + Mg ++ Cl - CH 3 COO - C 6 H 11 O 7 - (Acetate) (Gluconate) mmol/l 140 5.0 1.5 98 27 23 mEq/l 140 5.0 3.0 98 27 23 Fora full listofexcipients,seesection6.1. 3 PHARMACEUTICAL FORM Solutionforinfusion. Clearsolution,freefromvisibleparticles Osmolarity:572mOsm/l(approx.) pH:4.0to6.0 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Plasma-Lyte148&Glucose5%w/visindicated: - forfluidreplacementwithcarbohydratesupply(e.g.afterburns,headinjury,fracture,infection,andperitonealirritation), - asintraoperativefluidreplacement, - inmildtomoderatemetabolicacidosis,alsoincaseoflactatemetabolismimpairment. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION HealthProductsRegulatoryAuthority 22March2019 CRN008KF8 Page2of11 Adults, the Elderly, Adolescents and Children: Thedosageandrateofadministrationdependontheage,weight,clinicalandbiologicalconditionsofthepatientand concomitanttherapy. Fluidbalance,bloodglucose,andserumelectrolytesshouldbemonitoredbeforeandduringadministration(seesections4.4, 4.5,4.6and4.8). _Recommended dosage_: Therecommendeddosageis: - foradults,theelderlyandadolescents:500mlto3litres/ Read the complete document